JWH-307: Difference between revisions
Content deleted Content added
m Reverted edits by 46.118.214.13 (talk) to last version by MER-C |
No edit summary |
||
| Line 29: | Line 29: | ||
{{cannabinoid-stub}} |
{{cannabinoid-stub}} |
||
==Manufacture and Sale== |
|||
*[http://www.titaniumwf.com www.titaniumwf.com Laboratory producing and selling JWH-307] |
|||
==References== |
==References== |
||
Revision as of 15:22, 3 November 2010
 | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| PubChem CID | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C26H24FNO |
| Molar mass | 385.472 g/mol g·mol−1 |
| 3D model (JSmol) | |
| |
JWH-307 is an analgesic drug used in scientific research, which acts as a cannabinoid agonist at both the CB1 and CB2 receptors. It is somewhat selective for the CB2 subtype, with a Ki of 7.7nM at CB1 vs 3.3nM at CB2.[1] It was discovered by, and named after, Dr. John W. Huffman.
 | This cannabinoid related article is a stub. You can help Wikipedia by expanding it. |
Manufacture and Sale
References
- ^ Huffman JW, Padgett LW, Isherwood ML, Wiley JL, Martin BR. 1-Alkyl-2-aryl-4-(1-naphthoyl)pyrroles: New high affinity ligands for the cannabinoid CB1 and CB2 receptors. Bioorganic & Medicinal Chemistry Letters 2006; 16:5432-5435.